Cargando…
Strategies Towards Protease Inhibitors for Emerging Flaviviruses
Infections with flaviviruses are a continuing public health threat. In addition to vaccine development and vector control, the search for antiviral agents that alleviate symptoms in patients are of considerable interest. Among others, the flaviviral protease NS2B-NS3 is a promising drug target to in...
Autor principal: | Nitsche, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121277/ https://www.ncbi.nlm.nih.gov/pubmed/29845533 http://dx.doi.org/10.1007/978-981-10-8727-1_13 |
Ejemplares similares
-
NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus
por: Natarajan, Satheesh
Publicado: (2010) -
Insights into Structures and Dynamics of Flavivirus Proteases from NMR Studies
por: Li, Qingxin, et al.
Publicado: (2020) -
Antiviral Agents against Flavivirus Protease: Prospect and Future Direction
por: Samrat, Subodh K., et al.
Publicado: (2022) -
Acute neurologic emerging flaviviruses
por: Caldwell, Marissa, et al.
Publicado: (2022) -
Riboflavin, a Potent Neuroprotective Vitamin: Focus on Flavivirus and Alphavirus Proteases
por: Eberle, Raphael J., et al.
Publicado: (2022)